Prescription
g-Nomic®, the software for the interpretation of pharmacogenetics and drug interactions, reports on the genes for which the possible influence of response to each drug is known: normal-toxicity-therapeutic failure.
G-NOMIC® POWERFUL SOFTWARE
g-Nomic® contains, in its database, pharmacogenetic and drug interaction information obtained from FDA-EMA-AEMPS and international guidelines, as well as publications on medicinal plants. It also contains information on more than 1,100 genetic polymorphisms that may influence toxicity or efficacy. The powerful software interrelates this information and transforms it into a report that facilitates personalised prescribing for the clinician, to the benefit of his or her patients.
IDENTIFIES THE LEVEL OF EVIDENCE FOR EACH DRUG
g-Nomic® reports on genes, which may influence the response to each drug: normal, toxicity or therapeutic failure. It includes genetic polymorphisms, polymorphisms of drug metabolism enzymes as well as trans-membrane transporter proteins (drug pharmacokinetics) and therapeutic targets (pharmacodynamics). For each gene, the level of evidence is shown, according to the main guidelines, data sheets and relevant scientific publications.
DATABASE ALWAYS UPDATED
All the modifications published in the updates of the FDA, EMA and AEMPS technical data sheets are systematically reviewed, in addition to the periodic review of specialised publications. Everything relating to pharmacogenetics, drug interactions and adverse effects is entered or modified in the database.
Discover the power and simplicity of pharmacogenetics
A DNA test can be ordered to detect gene-drug interactions and actions in order to avoid any toxicity or therapeutic failure in the prescribed treatment.
